From Biopsy to Breakthrough: Real-world Genomics in Early-Stage Oncology Trials
In this episode, ConcertAI CEO Jeff Elton sits down with Mike Rossi, PhD - ConcertAI's Clinical Genomics Lead - to explore how real-world genomic and clinical data are transforming early-stage oncology research. From the evolution of next-generation sequencing to liquid biopsy innovations, they unpack how integrated data sources are helping biopharma optimize study design, reduce trial risk, and accelerate breakthroughs. With insights into AI-powered simulations, patient journey mapping, and the strategic shift toward real-time decision-making, this conversation is essential listening for anyone in translational medicine or clinical development. Websitewww.ConcertAI.comLinkedInwww.linkedin.com/company/concertai/Twitterwww.twitter.com/concertai
--------
21:46
The Future of Drug Development: AI, RWD, and Regulatory Insights feat. Evidera's Ariel Berger
In this episode of The ConcertAI Podcast, Jeff Elton, CEO of ConcertAI, engages with Ariel Berger, Executive Director of Integrated Solutions of Evidera, part of the PPD™ clinical research business of Thermo Fisher Scientific, to explore the innovative uses of real-world data (RWD) in regulatory settings, particularly in oncology. They discuss the critical role of RWD in shaping clinical trials and supporting regulatory decisions, emphasizing its growing importance in the regulatory approval process. The conversation also delves into the complexities of integrating AI and advanced data technologies to enhance trial designs and outcomes, highlighting how these tools are revolutionizing drug development efficiency and precision in patient care. Through insightful dialogue, the episode illuminates the transformative impact of these technologies on the future of healthcare and precision medicine.Websitewww.ConcertAI.comLinkedInwww.linkedin.com/company/concertai/Twitterwww.twitter.com/concertai
--------
42:15
Accelerating Healthcare Innovation with NVIDIA feat. Rory Kelleher
In the season three opener of The ConcertAI Podcast, our guest Rory Kelleher (Senior Director, Global Head of Business Development, Life Sciences) from NVIDIA delves into the transformative role of AI in healthcare and life sciences. With a rich background at NVIDIA, Rory shares insights into NVIDIA’s journey from a GPU manufacturer to a leader in AI computation. This episode explores NVIDIA’s initiatives like the Clara platform, which seamlessly integrates AI into medical imaging and genomics, significantly accelerating drug discovery and patient care processes. Rory and host, Jeff Elton, discuss the collaborative dynamics between ConcertAI and NVIDIA, focusing on innovative AI-driven models designed to revolutionize clinical trial design and execution. The future looks promising with the potential development of reasoning models and multimodal patient foundation models, poised to deliver personalized healthcare solutions more effectively. Tune in to discover how NVIDIA's technology is paving the way for advancements in life sciences.Websitewww.ConcertAI.comLinkedInwww.linkedin.com/company/concertai/Twitterwww.twitter.com/concertai
--------
44:00
Prostate Cancer Awareness with Steve Osunsami: Screening, Survival, and Breaking Stigmas
In this compelling episode of The ConcertAI Podcast, host Jeff Elton sits down with ABC's senior national correspondent, Steve Osunsami, to discuss the critical importance of prostate cancer screening and awareness. Steve shares his personal journey with prostate cancer, from initial diagnosis at age 41 to treatment and recovery. He highlights the significance of early detection, particularly for high-risk groups such as African American men, and the life-saving potential of regular PSA testing. Through his candid storytelling, Steve addresses the the challenges men face regarding prostate cancer, including the stigma around sexual function, and advocates for increased awareness and proactive health measures. This episode is a powerful reminder of the importance of self-advocacy and the need for tailored healthcare guidelines to better serve diverse populations. Websitewww.ConcertAI.comLinkedInwww.linkedin.com/company/concertai/Twitterwww.twitter.com/concertai
--------
40:40
Breaking New Ground in Prostate Cancer Research feat. Jennifer Rider and Kathryn Penney
September marks Prostate Cancer Awareness Month, and to honor this, our latest episode of the ConcertAI Podcast features a special session with top urological cancer specialists. Host Jeff Elton welcomes Jennifer Rider and Kathryn Penney to our studio in Harvard Square, Cambridge, MA. Both guests are distinguished cancer epidemiologists who bring a wealth of knowledge and experience in prostate cancer research. In this episode, you will hear about the personal journeys of our guests into the field of cancer research, the significant advancements they have contributed to, and the vital role of genetic studies in improving patient care. The discussion delves into the importance of the Gleason scoring system for determining patient prognosis and explores the integration of AI and digital pathology to enhance diagnosis and treatment strategies. This conversation is essential for anyone interested in the latest in prostate cancer research and the evolving treatment strategies that could redefine patient outcomes.Websitewww.ConcertAI.comLinkedInwww.linkedin.com/company/concertai/Twitterwww.twitter.com/concertai
Dive into the innovative world of oncology research with The ConcertAI Podcast! ConcertAI uses artificial intelligence to revolutionize the clinical development and delivery of cancer treatments, accelerating the delivery of precision oncology to patients in need. With real-world data, clinical trial matching, patient support, and more, ConcertAI is transforming the oncology landscape. These are rapidly changing fields which require very high expertise. Tune in twice a month as we bring subject matter experts together to take a deeper dive on topics of interest and relevance.To learn more about ConcertAI please visit us at www.ConcertAI.com
Ireland